Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study.

Shiyi SunLihong ChenDawei ChenYan LiGuanjian LiuLin MaJun LiFangwei CaoXing-Wu Ran

Published in: Therapeutic advances in endocrinology and metabolism (2023)

The study protocol was registered in the Chinese Clinical Trial Registry (http://www.chictr.org.cn/), and the registration number was ChiCTR 2100042742.

Keyphrases

clinical trial
study protocol
risk factors
randomized controlled trial
open label
double blind
lymph node metastasis
uric acid
phase ii
physical activity
phase iii
metabolic syndrome